The Relationship Between COVID-19 Anxiety Level and Emotional Eating in Individuals With Metabolic Syndrome

COVID-19 Clinical Trial

— COVID-19  

Official title:

The Relationship Between Coronavirus Anxiety Level and Emotional Eating in Individuals With Metabolic Syndrome

Clinical Trial Details — Status: Completed

Administrative data

• NCT number: NCT04912934
• Other study ID #: KAEK-228
• Status: Completed
• Start date: June 20, 2020
• Est. completion date: December 12, 2020

Study information

• Verified date: June 2021
• Source: T.C. ORDU ÜNIVERSITESI
• Contact: n/a
• Is FDA regulated: No
• Study type: Observational

Clinical Trial Summary

The aim was to determine the coronavirus anxiety levels and emotional eating status of cases with diagnosis of MetS according to diagnostic criteria published by the International Diabetic Federation (IDF) in 2005 and healthy individuals with similar BMI to MetS subjects.

Description:

The aim was to determine the coronavirus anxiety levels and emotional eating status of cases with diagnosis of MetS according to diagnostic criteria published by the International Diabetic Federation (IDF) in 2005 and healthy individuals with similar BMI to MetS subjects. This study was completed with the descriptive, cross-sectional and relational screening model. The full sampling method was used in the study. The study was completed with 105 individuals with metabolic syndrome attending the diet clinic and 109 healthy individuals without MetS diagnosis also attending the diet clinic. Collection of data used anthropometric measurements and biochemical findings, blood pressure and a survey form, the Coronavirus Anxiety Scale (CAS) and Emotional Eating Scale (EES).

Recruitment information / eligibility

• Status: Completed
• Enrollment: 214
• Est. completion date: December 12, 2020
• Est. primary completion date: November 20, 2020
• Accepts healthy volunteers: No
• Gender: All
• Age group: 18 Years to 70 Years

Eligibility

Inclusion Criteria:

• The research included individuals aged 18 years and older, who were not pregnant or breastfeeding, without any psychological disorder diagnosed by psychiatry, without diagnosis of COVID-19 and not using any psychiatric medications. The MetS group for the research included individuals with metabolic syndrome diagnosis according to IDF-2005 diagnostic criteria. The non MetS group in the research included healthy individuals not using any psychiatric medications, without any chronic disorder, and with similar BMI to the individuals in the subject group.

Exclusion Criteria:

• The research included individuals aged 18 years and older, who were pregnant or breastfeeding, with psychological disorder diagnosed by psychiatry, with diagnosis of COVID-19 and using psychiatric medications.

Related Conditions & MeSH terms

• COVID-19
• Emotional Eating
• Metabolic Syndrome
• Syndrome

Intervention

Procedure:
• A survey form was applied to individuals included in the study face-to-face.
This study was completed with a descriptive, cross-sectional and relational screening model

Locations

Country	Name	City	State
Turkey	Dilek alemdar	Ordu

Sponsors (1)

Lead Sponsor	Collaborator
T.C. ORDU ÜNIVERSITESI

Country where clinical trial is conducted

Turkey, 

References & Publications (1)

Zhang J, Zhang Y, Huo S, Ma Y, Ke Y, Wang P, Zhao A. Emotional Eating in Pregnant Women during the COVID-19 Pandemic and Its Association with Dietary Intake and Gestational Weight Gain. Nutrients. 2020 Jul 28;12(8). pii: E2250. doi: 10.3390/nu12082250. — View Citation

Outcome

Type	Measure	Description	Time frame	Safety issue
Primary	Coronavirus anxiety scale (CAS)	Total points of =9 on the scale shows dysfunctional anxiety related to coronavirus.	5 month
Primary	Emotional eating scale (EES)	High points on the scale show high levels of emotional eating behavior.	5 month.
Secondary	BMI (Body Mass Index)	kg/m^2	5 month.
Secondary	Glucose	mg/dL	5 month.
Secondary	Blood pressure	Systolic and diastolic blood pressure	5 month.
Secondary	HDL	mg/dL	5 month.
Secondary	LDL	mg/dL	5 month.
Secondary	triglycerides	mg/dL	5 month.
Secondary	HbA1c	HbA1c (%)	5 month.
Secondary	insulin	ng/ml	5 month.
Secondary	HOMA-IR	index	5 month.
Secondary	total cholesterol	mg/dL	Through study completion, an average of 5 month.
Secondary	CRP	mg/dL	5 month.